Neologics Bio 逻晟生物

NeoLogics Bioscience Co., Ltd is an early clinical stage biotech company with operation in Suzhou, China and San Diego, CA. We are focusing on biologic drug discovery and development for immune modulation, particularly for diseases like cancer, autoimmune and inflammation. Our company is committed to lead the innovation of truly BIC (best in class) and FIC (first in class) biological immunotherapies for the benefit of patients worldwide. We have integrated robust in silico data mining, analyzing and phenotypical target validation system to ensure a sustainable pipeline. We also leverage resources from mature CRO, CDMO in China to advance our pipeline to certain milestones. At Present, we have discovered few leading drug candidates into the IND enabling stage and more leads in early discovery stage. We welcome more motivated professionals to join us. 苏州逻晟生物医药有限公司是一家创新型国际化生物医药企业，专注于有国际竞争优势的FIC/BIC抗体类生物药研究与开发，坐落于高科技企业聚集地苏州工业园区BioBAY和美丽海滨城市加州圣地亚哥。公司获得多家知名资本的大力支持。目前公司已建立免疫调节靶点发现和功能验证平台Tier-A，可以筛选并验证多个全球新癌症免疫靶点；现聚焦平台的进一步完善、研发并全程推进新一代高临床需求的、具有差异化的原创抗体类生物药。逻晟生物同时也在通过全球范围内的技术授权、合作开发等多种形式实现平台的战略发展。 在逻晟生物，您可以在创新药生物学深耕，同知名KOL深度学习交流，对疾病的发生发展和治疗有更深刻的认识和见解，影响、决策、项目的推进方向并在科学上排故解难，打怪升级；也可以全程参与抗体创新药全过程，在经验丰富的产业界专家引导下和强大完善的团队中快速学习成长，研发新药好药，成就公司的同时实现自我，在人类对抗疾病的新药研发历史上留下自己的签章。